Renee Tannenbaum – Biography
Last update: April 10, 2026Executive profile
Renee was Board Director at Zogenix, and Head, Global Commercial Excellence at AbbVie. Renee Tannenbaum joined Cardiff Oncology in 2022.
Renee Tannenbaum is currentlyDirector at ANI Pharmaceuticals - View - ANI Pharmaceuticals org chart
Independent Director at Cardiff Oncology - View - Cardiff Oncology org chart
Create your alert
to follow the career of Renee Tannenbaum.
Education
Renee Tannenbaum has a Bachelor in Clinical Pharmacy from University of the Sciences in Philadelphia and a Master of Business Administration in Marketing and Management from Temple University.
They have also studied at University of the Sciences in Philadelphia :
Margaret Horn - Revolution Medicines
Robert Pietrusko - DBV Technologies
Jack Kelly - Alpha Cognition
Find more alumni from University of the Sciences in Philadelphia
They have also studied at Temple University :
Find more alumni from Temple University
More about Renee Tannenbaum
Do you need to know more about Renee Tannenbaum? More results.
Participate
Social media
- Renee Tannenbaum on Google News, X (Twitter), LinkedIn, YouTube
- View the pictures of Renee Tannenbaum
The colleagues of Renee Tannenbaum
Company Colleagues
- At ANI Pharmaceuticals, Renee Tannenbaum has 38 colleagues including Nikhil Lalwani (CEO & Director), Jeanne Thoma (Director)…
- At Cardiff Oncology, Renee Tannenbaum has 17 colleagues including Mani Mohindru (CEO & President), James Armitage (Director)…
Industry Colleagues
- In the Biotechnology industry, Renee Tannenbaum has 35,756 colleagues in 2,407 companies located in 42 countries. 16,877 executive movements have been recorded in the last 12 months. Learn more about Biotechnology.
Report an error
Update the org chart details of Renee Tannenbaum.
Get in Touch
Here are a few tips for establishing great contacts.
and ask for Renee Tannenbaum.
